9888À­Ë¹Î¬¼Ó˹

9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ÎÒÃǵķþÎñ

×÷ΪÖйúµÚÈý·½¼ì²âÓëÈÏÖ¤·þÎñµÄ¿ªÍØÕߺÍÁìÏÈÕߣ¬CTI9888À­Ë¹Î¬¼Ó˹¼ì²âΪȫÇò¿Í»§ÌṩһվʽĥÁ·¡¢²âÊÔ¡¢Ð£×¼¡¢ÈÏÖ¤¼°ÊÖÒÕ·þÎñ¡£

9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ÐÐÒµ½â¾ö¼Æ»®

·þÎñÄÜÁ¦ÒÑÖÜÈ«ÁýÕÖµ½·ÄÖ¯´ò°ç¼°Ð¬°ü¡¢Ó¤Í¯Íæ¾ß¼°¼Ò¾ÓÉúÑÄ¡¢µç×ÓµçÆ÷¡¢Ò½Ñ§¿µ½¡¡¢Ê³Îï¼°Å©²úÆ·……µÈÐÐÒµµÄ¹©Ó¦Á´ÉÏÏÂÓΡ£

9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ÌØÉ«·þÎñ

ÖÜÈ«°ü¹ÜÆ·ÖÊÓëÇå¾²£¬Íƶ¯ºÏ¹æÓëÁ¢Ò죬ÕÃÏÔÆ·ÅƾºÕùÁ¦£¬ÊµÏÖ¸ü¸ßÖÊÁ¿¡¢¸ü¿µ½¡¡¢¸üÇå¾²¡¢¸üÂÌÉ«µÄ¿ÉÒ»Á¬Éú³¤¡£

¼ÓÈëÎÒÃÇ
È˲ÅÕþ²ß
ÕÐÏÍÄÉÊ¿
9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
È˲ÅÕþ²ß
°ü¹ÜÔ±¹¤»ù±¾È¨ÒæÓ븣Àû £»ÌṩרҵÊÖÒÕÅàѵ£¬Ôö½øÔ±¹¤Éú³¤ £»¿ªÕ¹¸»ºñ¶à²ÊµÄ»î¶¯£¬Æ½ºâÔ±¹¤ÊÂÇéÓëÉúÑÄ¡£
9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ÕÐÏÍÄÉÊ¿
½Ó´ý¼ÓÈë9888À­Ë¹Î¬¼Ó˹¼ì²â¸÷ÈËÍ¥£¬ÎÒÃǽ«ÎªÄã´î½¨Ò»¸ö³ä·ÖÑéÕ¹²Å»ª£¬ÊµÏÖÖ°ÒµÀíÏëµÄÎę̀¡£
9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ÐÂÎÅ×ÊѶ

ÔØÖ¬ÂѰ×E£¨APOE£©»ùÒò¼ì²â

Ðû²¼Ê±¼ä£º2024-09-27 ä¯ÀÀ´ÎÊý£º1555

1973Ä꣬Ñо¿Ö°Ô±ÔÚÒ»ÖÖÓÐÊýµÄÖ¬ÖÊ´úлÔÓÂÒ(³ÆÎª¼Ò×åÐԸߵ¨¹Ì´¼ÑªÖ¢IIIÐÍ)»¼Õߵ﫵ÍÃܶÈÖ¬ÂѰ×(VLDL)Öз¢Ã÷ÁËÒ»ÖÖ¸»º¬¾«°±ËáµÄÂѰ×Öʱ»ÃüÃûÎªÔØÖ¬ÂѰ×E(APOE,Apolipoprotein E)¡£Ô½À´Ô½¶àµÄÑо¿·¢Ã÷APOEÔÚÖ¬ÖÊ´úл¡¢ÐÄѪ¹Ü¼²²¡(CVD)ºÍ°¢¶û´Äº£Ä¬²¡(AD)ÖÐʩչÖ÷Òª×÷Óá£

 

9888À­Ë¹Î¬¼Ó˹(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ͼƬȪԴ£ºgenetrace


ʲôÊÇAPOE£¿

APOE»ùÒòλÓÚ19ºÅȾɫÌå,±àÂëÔØÖ¬ÂѰ×E(APOE),ÊÇѪ½¬ÖÐÖ÷ÒªµÄÔØÖ¬ÂѰ×Ö®—¡£¸ÃÂѰ׼ÓÈë»úÌåѪ֬µ÷Àí¡¢µ¨¹Ì´¼Æ½ºâ¡¢ÖÐÊàÉñ¾­ÏµÍ³ÊÜËðÉñ¾­ÔªµÄÐÞ¸´,¾ßÓÐÖ÷ÒªÐÄÀíѧ¹¦Ð§¡£

 

APOE»ùÒòµÄ½á¹¹ºÍ¹¦Ð§

APOE»ùÒò°üÀ¨ËĸöÍâÏÔ×ÓºÍÈý¸öÄÚº¬×Ó£¬±àÂëÒ»¸öÓÉ299¸ö°±»ùËá×é³ÉµÄÂѰ×ÖÊ£¬Ô¼34 kDa¡£Ö¬ÂѰ×EÊÇÒ»ÖÖÔØÖ¬ÂѰ×£¬Ö÷Òª±£´æÓÚѪ½¬ÖеÄÖ¬ÂѰ׿ÅÁ£ÖУ¬È缫µÍÃܶÈÖ¬ÂѰף¨VLDL£©¡¢µÍÃܶÈÖ¬ÂѰף¨LDL£©ºÍ¸ßÃܶÈÖ¬ÂѰף¨HDL£©¡£Ö¬ÂѰ×E¼ÓÈëÖ¬ÖʵÄÔËÊäºÍ´úл£¬µ÷Àíµ¨¹Ì´¼ºÍ¸ÊÓÍÈýõ¥µÄˮƽ¡£

 

APOE»ùÒòµÄ¶à̬ÐÔ

APOE»ùÒòÓÐ2¸öSNPλµãrs429358ºÍrs7412×é³É3ÖÖÏà¶Ô³£¼ûµ¥±¶ÐÍε2¡¢ε3¡¢ε4,Ï໥×éºÏÐγÉ6ÖÖÖ÷Òª»ùÒòÐÍε2ε2¡¢ε2ε3¡¢ε3ε3¡¢ε2ε4¡¢ε3ε4¡¢ε4ε4×é³ÉÈýÖÖÒì¹¹Ìå (APOE E2¡¢E3¡¢E4)¡£ÕâЩµÈλ»ùÒò±àÂëµÄÖ¬ÂѰ×EÔڽṹÉÏÂÔÓвî±ð£¬µ¼ÖÂÆäÔÚ¹¦Ð§ºÍ´úлÉϵIJî±ð¡£

 

Ö÷񻂿±ðÊÇÆäDNAÐòÁÐÉÏÊöÁ½¸öλµãµÄ¼î»ù²î±ð,Ôì³ÉËüÃÇËù±àÂëµÄÂѰ×ÔÚµÚ112λºÍµÚ158λµÄ°±»ùËá²Ð»ù±¬·¢ÁËת±ä¡£APOE2ÔÚÁ½¸öλµãÉϾùΪ°ëë×°±Ëá (Cys)£¬APOE3ÔÚµÚ112λΪ°ëë×°±Ëá,¶øµÚ158λΪ¾«°±Ëá (Arg)£¬APOE4ÔÚÁ½¸öλµãÉϾùΪ¾«°±Ëá¡£ÆäÖÐE4ÐÍ»áÔöÌí°¢¶û´Äº£Ä¬²¡¡¢Â·Ò×Ìå³Õ´ôµÄ·¢²¡Î£º¦£¬Í¬Ê±Ò²»áʹѪ½¬µ¨¹Ì´¼ºÍµÍÃܶÈÖ¬ÂѰ׵ÄˮƽÉý¸ß£¬´Ó¶øÔöÌíÐÄÄÔѪ¹Ü¼²²¡µÄ·¢²¡Î£º¦¡£

 

APOE»ùÒòµÄ¶à̬ÐÔÓë¶àÖÖ¼²²¡µÄ¹ØÏµ

£¨1£©Ó붯ÂöÖàÑùÓ²»¯

Ѫ½¬ÖÐѪ֬ÈôÊǹý¶àÈÝÒ×Ôì³É“Ѫ³í”£¬ÔÚѪ¹Ü±ÚÉϳÁ»ý,Öð½¥ÐγÉС°ß¿é¡£ÓÉÓÚ¹ý¶àÖ¬·¾³Á»ý,Ôì³É¶¯ÂöÓ²»¯ ʹѪÁ÷ÊÜ×è,ÛÕ±ÕѪҺÁ÷ÈëÏìÓ¦²¿Î»,ÒýÆð¹¦Ð§È±Ëð,±¬·¢ÔÚ¹Ú×´¶¯Âöʱ¿ÉÒýÆð¹ÚÐIJ¡,±¬·¢ÔÚÄÔѪ¹ÜʱÒ×±¬·¢ÄÔ¹£ËÀ¡£Ð¯´øAPOE ε2µÈλ»ùÒòÕß,¶Ô¶¯ÂöÖàÑùÓ²»¯ÓзÀ»¤×÷Ó᣶øÐ¯´øAPOE ε4µÈλ»ùÒòÕß,µ¨¹Ì´¼¼°¸ÊÓÍÈýõ¥º¬Á¿¸ß,ÊǶ¯ÂöÖàÑùÓ²»¯µÄDZÔÚΣÏÕÒòËØ¡£

 

£¨2£©Óë°¢¶û´Äº£Ä¬²¡

°¢¶û´Äº£Ä¬²¡ (ÍíÄê³Õ´ôÖ¢)ÊÇ—ÖÖÉñ¾­ÍËÐÐÐÔ¼²²¡,·ÖΪÔç·¢Ðͺͳٷ¢ÐÍ,ÆäÖгٷ¢ÐͽÏΪ³£¼û¡£¶øAPOE ε4µÈλ»ùÒòÓë³Ù·¢ÐÍΣº¦ÓйØ¡£´ó×ÚѪ֬ÔÚÄÔ²¿³Á»ý,Ó°ÏìÄÔµ¨¹Ì´¼ÎÈ̬,µ¼ÖÂϸ°ûÍâÉñ¾­Ñ×ÐÔ°ß¿éºÍϸ°ûÄÚÉñ¾­ÔªÏËά¾À¸ð,ÔöÌí°¢¶û´Äº£Ä¬²¡µÄ»¼²¡Î£º¦¡£

 

Σº¦ÐÍ»ùÒòÈËȺµÄ°¢¶û´Äº£Ä¬²¡±¬·¢Î£º¦¿É´ïͨË×ÈËȺµÄ10±¶ÒÔÉÏ¡£Òò´Ë¿ÉÒÔͨ¹ýAPOE»ùÒò¼ì²âÀ´Éó²é×Ô¼ºÊÇ·ñΪΣº¦ÐÍ,¶Ô¿É¿ØµÄΣÏÕÒòËØ¾ÙÐÐÔçÆÚ¸ÉÔ¤,50%ÒÔÉϵÄAPOE ε4»ùÒòЯ´øÕß²»»áÉú³¤³É°¢¶û´Äº£Ä¬²¡¡£

 

£¨3£©ÔØÖ¬ÂѰ×EÓëËûÍ¡ÀàÒ©Îï 

ËûÍ¡ÀàÒ©ÎïÊÇÏÖÔÚÓ¦ÓÃ×îÆÕ±éµÄ½µÖ¬Ò©ÎïÖ®—£¬ÄÜÓÐÓ÷ÀÖÎÐÄÄÔѪ¹Ü¼²²¡µÄ±¬·¢¡£²»µ«ÄÜǿЧµØ½µµÍ×ܵ¨¹Ì´¼(TC)ºÍµÍÃܶÈÖ¬ÂѰ×(LDL)£¬²¢ÇÒÄÜ—¶¨Ë®Æ½ÉϽµµÍ¸ÊÓÍÈýõ¥(TG)£¬Éý¸ß¸ßÃܶÈÖ¬ÂѰ×(HDL)¡£

 

Ñо¿Ö¤Êµ£¬ËûÍ¡ÀàÒ©Îï½µÖ¬ÖÎÁÆÐ§¹ûÓëAPOE»ùÒò¶à̬ÐÔÓйØ¡£APOE3ÐÍЯ´øÕßʹÓÃËûÍ¡ÀàÒ©ÎïÁÆÐ§Õý³£¡£¶øÁíÍâÁ½ÖÖ±äÒìÐÍ£¬APOE2ÐÍЯ´øÕßʹÓÃËûÍ¡ÀàÒ©ÎïÁÆÐ§½ÏºÃ£¬APOE4ÐÍЯ´øÕßʹÓÃËûÍ¡ÀàÒ©ÎïÁÆÐ§ÍùÍù²»¼Ñ¡£

 

ÔØÖ¬ÂѰ×E£¨APOE£©»ùÒò¼ì²â

¼ì²âÒâÒ壺APOE»ùÒò¼ì²âЧ¹û·´Ó¦µÄÊÇÓëÂѰ׹¦Ð§Ç×½üÏà¹ØµÄÐÄÄÔѪ¹Ü¼²²¡µÄ»¼²¡Î£º¦¡¢ËûÍ¡ÀàÓÃÒ©½¨Òé¡£ÐÄÄÔѪ¹Üϵͳ¼²²¡»¼²¡Î£º¦Í¬Ê±ÊÜÇéÐΡ¢Òûʳ¡¢Ô˶¯µÈ¶àÖÖÒòËØÓ°Ï죬¶ø¶ÔÒ©ÎïÁÆÐ§µÄÕ¹ÍûÒ²»áÊÜÇéÐΡ¢Òûʳ¡¢ÐÄÀí²¡Àí״̬¼°ºÏ²¢ÓÃÒ©µÈÖØ´óÇéÐεÄ×ÌÈÅ¡£Æ¾Ö¤¼ì²âЧ¹û¶¨ÖÆÔ¤·À½¨Ò飬Æð¾¢¾ÙÐпµ½¡¹ÜÀí£¬¾¡ÔçÔ¤·À£¬ÊµÊ±¸ÉÔ¤¡£

 

¼ì²âÒªÁ죺 PCR

 

²Î¿¼ÎÄÏ×

[1] wang QY, wang wJ, wu L, et al. Meta- analysis of ApOE ε2/ ε3/ ε4 polymorphism and cerebral infarction[J]. Journal of Neural Transmission, 2013, 120(10):1479-1489.

[2] zhang M, Gu w, Qiao S, et al. Apolipoprotein E Gene polymorphism and Risk for coronary Heart Disease in the chinese population: A Meta- Analysis of 61 Studies lncluding 6634 cases  and 6393 controls[J]. Journal of the American college of cardiology, 2014, 9(4):e95463.

[3] Liu M, Bian c, zhang J, et al. Apolipoprotein E gene polymorphism and Alzheimer,s disease in chinese population: a meta-analysis[J]. Scienti?c Reports, 2013, 4(4):4383.

[4] Thompson JF,  Hyde cL, wood LS, paciga SA, Hinds DA, cox DR, Hovingh GK, Kastelein JJ. comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort. circ cardiovasc Genet. 2009 Apr;2(2):173-81.

[5] Courtney M, Kloske,Michael E, Belloy,Elizabeth E, Blue et al. Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference.[J] .Alzheimers Dement, 2024, 0: 0.

ÍøÕ¾µØÍ¼